New Zealand markets closed

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
95.16-0.28 (-0.29%)
At close: 04:00PM EST
94.70 -0.46 (-0.48%)
After hours: 05:43PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 259.97B
Enterprise value 256.69B
Trailing P/E 37.50
Forward P/E 34.36
PEG ratio (5-yr expected) 3.30
Price/sales (ttm)12.87
Price/book (mrq)25.85
Enterprise value/revenue 1.91
Enterprise value/EBITDA 4.06

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 336.40%
S&P500 52-week change 317.58%
52-week high 3117.35
52-week low 366.59
50-day moving average 3107.73
200-day moving average 395.48

Share statistics

Avg vol (3-month) 31.29M
Avg vol (10-day) 31.58M
Shares outstanding 52.28B
Implied shares outstanding 6N/A
Float 81.63B
% held by insiders 10.01%
% held by institutions 17.77%
Shares short (30 Dec 2021) 42.81M
Short ratio (30 Dec 2021) 42.17
Short % of float (30 Dec 2021) 4N/A
Short % of shares outstanding (30 Dec 2021) 40.12%
Shares short (prior month 29 Nov 2021) 41.91M

Dividends & splits

Forward annual dividend rate 41.47
Forward annual dividend yield 41.55%
Trailing annual dividend rate 39.35
Trailing annual dividend yield 39.80%
5-year average dividend yield 42.29
Payout ratio 446.62%
Dividend date 324 Aug 2021
Ex-dividend date 415 Aug 2021
Last split factor 25:1
Last split date 308 Jan 2014

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 34.31%
Operating margin (ttm)42.00%

Management effectiveness

Return on assets (ttm)22.50%
Return on equity (ttm)73.49%

Income statement

Revenue (ttm)134.6B
Revenue per share (ttm)58.39
Quarterly revenue growth (yoy)15.20%
Gross profit (ttm)106.01B
EBITDA 60.42B
Net income avi to common (ttm)46.18B
Diluted EPS (ttm)3.04
Quarterly earnings growth (yoy)17.70%

Balance sheet

Total cash (mrq)35.39B
Total cash per share (mrq)15.44
Total debt (mrq)13.75B
Total debt/equity (mrq)20.80
Current ratio (mrq)1.03
Book value per share (mrq)28.85

Cash flow statement

Operating cash flow (ttm)58.19B
Levered free cash flow (ttm)32.65B